Oramed Pharmaceuticals Statistics

Total Valuation

TLV:ORMP has a market cap or net worth of ILS 325.51 million. The enterprise value is -205.00 million.

Market Cap	325.51M
Enterprise Value	-205.00M

Important Dates

The last earnings date was Friday, March 7, 2025.

Earnings Date	Mar 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.65%
Shares Change (QoQ)	-0.56%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	32.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	0.61
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	2.95
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	6.68

Financial Position

The company has a current ratio of 25.19, with a Debt / Equity ratio of 0.00.

Current Ratio	25.19
Quick Ratio	24.97
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.04
Interest Coverage	-14.98

Financial Efficiency

Return on equity (ROE) is -12.39% and return on invested capital (ROIC) is -4.43%.

Return on Equity (ROE)	-12.39%
Return on Assets (ROA)	-4.25%
Return on Invested Capital (ROIC)	-4.43%
Return on Capital Employed (ROCE)	-8.54%
Revenue Per Employee	n/a
Profits Per Employee	-17.36M
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -30.94% in the last 52 weeks. The beta is 1.61, so TLV:ORMP's price volatility has been higher than the market average.

Beta (5Y)	1.61
52-Week Price Change	-30.94%
50-Day Moving Average	827.36
200-Day Moving Average	870.34
Relative Strength Index (RSI)	39.31
Average Volume (20 Days)	12,593

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.63

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-46.55M
Pretax Income	-57.99M
Net Income	-69.42M
EBITDA	-45.85M
EBIT	-46.55M
Earnings Per Share (EPS)	-1.75

Full Income Statement

Balance Sheet

The company has 516.95 million in cash and 1.35 million in debt, giving a net cash position of 515.60 million.

Cash & Cash Equivalents	516.95M
Total Debt	1.35M
Net Cash	515.60M
Net Cash Per Share	n/a
Equity (Book Value)	529.40M
Book Value Per Share	13.35
Working Capital	500.95M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -30.64 million and capital expenditures -65,561, giving a free cash flow of -30.70 million.

Operating Cash Flow	-30.64M
Capital Expenditures	-65,561
Free Cash Flow	-30.70M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TLV:ORMP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.65%
Shareholder Yield	-0.65%
Earnings Yield	-21.33%
FCF Yield	-9.43%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a